Form 4: Baxter International Director Stephen N. Oesterle Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Stephen N. Oesterle reports acquiring 5,952 shares of Baxter International Inc. common stock on May 7, 2024, through a grant and dividend reinvestment.
Summary
- On May 7, 2024, Stephen N. Oesterle, a director of Baxter International Inc., acquired 5,952 shares of common stock.
- These shares were obtained through a grant of fully vested shares and the automatic reinvestment of dividends.
- Following the transaction, Oesterle's total holdings amount to 27,901 shares of Baxter International Inc. common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment. This is a standard regulatory filing indicating a director's acquisition of shares. The acquisition itself could be seen as a positive signal, but the filing is primarily informational.
Positives
- The acquisition of shares by a director may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares as a positive sign of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| February 12, 2024 | Date of execution of the Power of Attorney. |
| May 07, 2024 | Date of transaction: Stephen N. Oesterle acquired shares of Baxter International Inc. common stock. |
| May 09, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.